Suchergebnisse - "Patel, Jai N"

PubPharm (101)

1

Recommendations for pharmacogenetic testing in clinical practice guidelines in the US

enthalten in: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists | 2024

von Hertz, D. | Bousman, C. | McLeod, H. | +8

2

Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance)

enthalten in: The pharmacogenomics journal | 2024

von Patel, J. | Jiang, C. | Owzar, K. | +17

3

PD-1/PD-L1 inhibitor-induced immune thrombocytopenia : A pharmacovigilance study and systematic review

enthalten in: International immunopharmacology | 2024

von Moore, D. | Elmes, J. | Arnall, J. | +2

4

Alpelisib-Induced Diabetic Ketoacidosis : A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System and Review of the Literature

enthalten in: Clinical breast cancer | 2024

von Ziegengeist, J. | Elmes, J. | Strassels, S. | +2

5

Hepatitis B reactivation in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based therapies : a pharmacovigilance analysis

enthalten in: International journal of clinical pharmacy | 2023

von Moore, D. | Elmes, J. | Arnall, J. | +2

6

Genetic Predictors of Ibrutinib-related Cardiovascular Side Effects in Patients with Chronic Lymphocytic Leukemia

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Hamadeh, I. | Patel, J. | Jacobs, R. | +11

7

Opioid Monitoring Using Urine Toxicology Screens in Outpatient Oncology Palliative Medicine

enthalten in: JCO oncology practice | 2023

von Patel, J. | Jandrisevits, E. | Boselli, D. | +3

8

Pharmacogenetic and clinical predictors of voriconazole concentration in hematopoietic stem cell transplant recipients receiving CYP2C19-guided dosing

enthalten in: The pharmacogenomics journal | 2023

von Patel, J. | Robinson, M. | Morris, S. | +9

9

Response to the FDA Decision Regarding DPYD Testing Prior to Fluoropyrimidine Chemotherapy

enthalten in: Clinical pharmacology and therapeutics | 2023

von Hertz, D. | Smith, D. | Scott, S. | +2

CommentIn: Clin Pharmacol Ther. 2023 Oct;114(4):733-737. - PMID 37713298

10

Use of patient-reported outcome measures for oncology drugs receiving accelerated approval

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2023

von Moore, D. | Elmes, J. | Strassels, S. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]